Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
6.42
-0.03 (-0.39%)
Apr 29, 2026, 9:37 AM EDT - Market open
Minerva Neurosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 82.3 | 21.36 | 40.91 | 36.09 | 60.76 | Upgrade
|
| Cash & Short-Term Investments | 82.3 | 21.36 | 40.91 | 36.09 | 60.76 | Upgrade
|
| Cash Growth | 285.27% | -47.79% | 13.35% | -40.59% | 139.60% | Upgrade
|
| Other Receivables | - | - | - | 3.12 | - | Upgrade
|
| Receivables | - | - | - | 3.12 | - | Upgrade
|
| Prepaid Expenses | 0.7 | 0.81 | 0.99 | 0.85 | 1.35 | Upgrade
|
| Restricted Cash | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | Upgrade
|
| Total Current Assets | 83.1 | 22.27 | 42 | 40.16 | 62.2 | Upgrade
|
| Property, Plant & Equipment | - | 0.01 | 0.01 | 0.02 | - | Upgrade
|
| Goodwill | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | Upgrade
|
| Other Intangible Assets | - | - | 0.02 | 0.04 | 0.05 | Upgrade
|
| Total Assets | 97.97 | 37.14 | 56.9 | 55.09 | 77.12 | Upgrade
|
| Accounts Payable | 0.64 | 1.61 | 1.81 | 0.97 | 1.85 | Upgrade
|
| Accrued Expenses | 1.65 | 1.23 | 1.54 | 0.41 | 0.97 | Upgrade
|
| Total Current Liabilities | 2.29 | 2.84 | 3.34 | 1.38 | 2.82 | Upgrade
|
| Long-Term Debt | 60 | 60 | 82.02 | 73.73 | 66.33 | Upgrade
|
| Other Long-Term Liabilities | 171.46 | - | - | - | - | Upgrade
|
| Total Liabilities | 233.76 | 62.84 | 85.36 | 75.11 | 69.15 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 548.05 | 369.68 | 368.36 | 346.79 | 342.68 | Upgrade
|
| Retained Earnings | -688.8 | -395.38 | -396.82 | -366.81 | -334.7 | Upgrade
|
| Total Common Equity | -140.75 | -25.69 | -28.46 | -20.02 | 7.98 | Upgrade
|
| Shareholders' Equity | -135.79 | -25.69 | -28.46 | -20.02 | 7.98 | Upgrade
|
| Total Liabilities & Equity | 97.97 | 37.14 | 56.9 | 55.09 | 77.12 | Upgrade
|
| Total Debt | 60 | 60 | 82.02 | 73.73 | 66.33 | Upgrade
|
| Net Cash (Debt) | 22.3 | -38.64 | -41.1 | -37.64 | -5.57 | Upgrade
|
| Net Cash Per Share | 2.64 | -5.10 | -6.32 | -7.05 | -1.04 | Upgrade
|
| Filing Date Shares Outstanding | 43.27 | 6.99 | 6.99 | 5.34 | 5.34 | Upgrade
|
| Total Common Shares Outstanding | 43.27 | 6.99 | 6.99 | 5.34 | 5.34 | Upgrade
|
| Working Capital | 80.81 | 19.43 | 38.66 | 38.78 | 59.38 | Upgrade
|
| Book Value Per Share | -3.25 | -3.67 | -4.07 | -3.75 | 1.49 | Upgrade
|
| Tangible Book Value | -155.62 | -40.56 | -43.34 | -34.94 | -6.94 | Upgrade
|
| Tangible Book Value Per Share | -3.60 | -5.80 | -6.20 | -6.54 | -1.30 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.